北美麻醉药市场 - 增长、趋势、COVID-19 影响和预测 (2023 - 2028)

北美麻醉药物市场按药物类型、给药途径(吸入、注射和其他给药途径)、应用和地理划分。

市场快照

CAGR
Study Period: 2018 - 2026
CAGR: 3.5 %

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计北美麻醉药市场在预测期内的复合年增长率将接近 3.5%。

据美国人口普查局统计,截至2017年,65岁及以上人口总数已超过5000万,预计2020年至2030年间,老年人口将增加近1800万。尽管总体规模要小得多,但预计 85 岁及以上的人数将从目前估计的 600 万增加到 2060 年的近 2000 万的三倍多。老年患者的围手术期发病率可能更高和死亡率。老年人群往往患有更多的危重疾病,这使他们面临更高的围手术期发病风险。老年人群发生器官功能衰竭的风险也较高,因为与年龄和器官功能相关的药代动力学和药效学发生了变化。随着老年患者比例的增加,患者患心脏和肺部疾病、肾脏和肝脏功能改变以及呼吸道和泌尿道并发症的风险将会增加。手术数量的整体增加将对麻醉剂市场产生强烈影响,从而推动该地区市场的增长。

报告范围

麻醉是一种导致可逆性感觉丧失的药物。市场上有几种麻醉药物可供选择,例如全身麻醉、脊髓麻醉、IV 区域麻醉、局部麻醉、周围神经阻滞和鞍座阻滞或尾部麻醉。

By Drug Type
General Anesthesia Drugs
Propofol
Sevoflurane
Desflurane
Dexmedetomidine
Remifentanil
Midazolam
Isoflurane
Other General Anesthesia Drugs
Local Anesthesia Drugs
Bupivacaine
Ropivacaine
Lidocaine
Chloroprocaine
Articaine
Benzocaine
Other Local Anesthesia Drugs
By Route of Administration
Inhalation
Injection
Other Routes of Administration
By Application
General Surgeries
Plastic Surgery
Cosmetic Surgeries
Dental Surgeries
Other Applications
Geography
North America
United States
Canada
Mexico

Report scope can be customized per your requirements. Click here.

主要市场趋势

全身麻醉药物异丙酚细分市场有望呈现健康增长态势

异丙酚是一种长期用于需要麻醉的各种外科手术的药物。随着手术数量的增加和该地区老年人口的增加,该细分市场的增长也有所增加。一些生产丙泊酚注射剂的公司是 Neon Laboratories Limited、Bharat Serums and Vaccines Limited 和 Fresenius Kabi,在该领域的药物拥有良好的全球影响力和完善的分销渠道。该药物在市场上一直有需求,可用于不同类型的手术,预计未来几年将出现快速增长。

elder

竞争格局

北美麻醉药品市场竞争激烈,由几家主要参与者组成。就市场份额而言,目前很少有主要参与者主导市场。然而,随着药品批准数量的增加,中小型公司正在通过引入价格更低的新成分来增加其市场占有率。Baxter International、Fresenius SE & Co. KGaA、Eisai Co. Ltd、Roche Holding AG 和 B. Braun Melsungen AG 等公司在麻醉药品市场占有相当大的市场份额。

主要玩家

  1. B. Braun Melsungen AG

  2. Baxter International

  3. Eisai Co., Ltd.

  4. Fresenius SE & Co. KGaA

  5. AbbVie Inc.

*Disclaimer: Major Players sorted in no particular order

North America Anesthesia Drugs Market.png

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Number of Surgeries

      2. 4.2.2 Growing Investment in R&D by the Pharmaceutical Companies

    3. 4.3 Market Restraints

      1. 4.3.1 Side Effects of General Anesthetics

      2. 4.3.2 Regulatory Issues

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Drug Type

      1. 5.1.1 General Anesthesia Drugs

        1. 5.1.1.1 Propofol

        2. 5.1.1.2 Sevoflurane

        3. 5.1.1.3 Desflurane

        4. 5.1.1.4 Dexmedetomidine

        5. 5.1.1.5 Remifentanil

        6. 5.1.1.6 Midazolam

        7. 5.1.1.7 Isoflurane

        8. 5.1.1.8 Other General Anesthesia Drugs

      2. 5.1.2 Local Anesthesia Drugs

        1. 5.1.2.1 Bupivacaine

        2. 5.1.2.2 Ropivacaine

        3. 5.1.2.3 Lidocaine

        4. 5.1.2.4 Chloroprocaine

        5. 5.1.2.5 Articaine

        6. 5.1.2.6 Benzocaine

        7. 5.1.2.7 Other Local Anesthesia Drugs

    2. 5.2 By Route of Administration

      1. 5.2.1 Inhalation

      2. 5.2.2 Injection

      3. 5.2.3 Other Routes of Administration

    3. 5.3 By Application

      1. 5.3.1 General Surgeries

      2. 5.3.2 Plastic Surgery

      3. 5.3.3 Cosmetic Surgeries

      4. 5.3.4 Dental Surgeries

      5. 5.3.5 Other Applications

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Aspen Holdings

      2. 6.1.2 AbbVie Inc.

      3. 6.1.3 AstraZeneca

      4. 6.1.4 Baxter International

      5. 6.1.5 B. Braun Melsungen AG

      6. 6.1.6 Eisai Co. Ltd

      7. 6.1.7 Pfizer Inc.

      8. 6.1.8 F. Hoffmann-La Roche AG

      9. 6.1.9 Fresenius SE & Co. KGaA

      10. 6.1.10 Novartis AG (Sandoz)

      11. 6.1.11 Piramal Enterprises Limited

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

从 2018 年到 2028 年研究了北美麻醉药市场。

北美麻醉药品市场在未来 5 年内将以 3.5% 的复合年增长率增长。

B. Braun Melsungen AG、Baxter International、Fresenius SE & Co. KGaA、AbbVie Inc.、Eisai Co. Ltd 是在北美麻醉药品市场运营的主要公司。

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!